These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19480789)

  • 1. [Aviremic HIV infection: "elite controller" patients].
    Belda Mira A; López Montes L; Jiménez Pérez de Heredia I; Roldán Silvestre A
    Rev Clin Esp; 2009 May; 209(5):260-1. PubMed ID: 19480789
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of the HIV-specific CD8+ T-cell response in an HIV elite controller after chikungunya virus infection.
    Ghiglione Y; Ruiz MJ; Salido J; Trifone C; Sued O; Martin Y; Patterson P; Laufer N; Turk G
    AIDS; 2016 Jul; 30(12):1905-11. PubMed ID: 27124898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elite control of HIV Infection: implications for vaccines and treatment.
    Walker BD
    Top HIV Med; 2007; 15(4):134-6. PubMed ID: 17720999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
    Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H
    Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal platelet numbers correlate with plasma viral load and CD4+ cell counts in HIV-1 infection.
    Nicolle M; Levy S; Amrhein E; Schmitt MP; Partisani M; Rey D; Lang JM
    Eur J Haematol; 1998 Sep; 61(3):216-7. PubMed ID: 9753420
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous resolution of HIV-associated nephropathy in an elite controller.
    Blankson JN; Basseth CR; Kuperman M; Fine DM
    AIDS; 2011 May; 25(8):1135-7. PubMed ID: 21537117
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney transplantation in an elite HIV controller: limited impact of immunosuppressive therapy on viro-immunological status.
    Lambotte O; Lecuroux C; Saez-Cirion A; Barbet C; Shin SY; Boufassa F; Bastides F; Lebranchu Y
    J Infect; 2012 Jun; 64(6):630-3. PubMed ID: 22406689
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
    Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pregnancy in an HIV elite controller.
    Rutland E; Mani R
    Int J STD AIDS; 2010 Aug; 21(8):604-5. PubMed ID: 20975097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care.
    Dickinson BP; Mitty JA; Mylonakis E; Rich JD; Merriman NA; Tashima KT; Carpenter CC; Flanigan TP
    AIDS; 1998 Oct; 12(15):2075-6. PubMed ID: 9814878
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase.
    Harritshoj LH; Dickmeiss E; Hansen MB; Ullum H; Jorgensen LB; Gerstoft J
    Transfusion; 2008 Sep; 48(9):2026-8. PubMed ID: 18811898
    [No Abstract]   [Full Text] [Related]  

  • 13. High viremia in HIV-1 subtype C infection and spread of the epidemic.
    Neogi U; Palchaudhuri R; Shet A
    J Infect Dis; 2013 Sep; 208(5):866-7. PubMed ID: 23757339
    [No Abstract]   [Full Text] [Related]  

  • 14. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease.
    von Giesen HJ; Adams O; Köller H; Arendt G
    J Neurol; 2005 Jul; 252(7):801-7. PubMed ID: 15750706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity].
    García Lerma JG; Heneine W
    Med Clin (Barc); 1998 Apr; 110(12):453-4. PubMed ID: 9611714
    [No Abstract]   [Full Text] [Related]  

  • 17. [Difficulty in measuring the viral load in the course of a HIV infection in the infant].
    Sellam E; Ranger S; de Lumley L; Piguet C; Ketterer S; Guibert J; Gilbert B
    Arch Pediatr; 1998 Apr; 5(4):462-3. PubMed ID: 9759175
    [No Abstract]   [Full Text] [Related]  

  • 18. Examining HIV Viral Load in a Matched Cohort of HIV Positive Individuals With and Without Psoriasis.
    Wu JJ; Gilbert KE; Batech M; Manalo IF; Towner WJ; Raposo RA; Nixon DF; Liao W
    J Drugs Dermatol; 2017 Apr; 16(4):372-377. PubMed ID: 28403272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV viral load. Current situation and perspectives].
    Arnal J
    Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):507-9. PubMed ID: 9522513
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of plasma HIV viral load--clinical applications.
    Churchill D; Weber J
    J Infect; 1999 May; 38(3):147-50. PubMed ID: 10424792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.